These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 15736291

  • 1. Telmisartan vs. enalapril in type 2 diabetes.
    Loewenstein JE.
    N Engl J Med; 2005 Feb 24; 352(8):835-6; author reply 835-6. PubMed ID: 15736291
    [No Abstract] [Full Text] [Related]

  • 2. Telmisartan vs. enalapril in type 2 diabetes.
    Asgari AA, Sarvghadi F, Zahed N.
    N Engl J Med; 2005 Feb 24; 352(8):835-6; author reply 835-6. PubMed ID: 15728820
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J, Diabetics Exposed to Telmisartan and Enalapril Study Group.
    N Engl J Med; 2004 Nov 04; 351(19):1952-61. PubMed ID: 15516696
    [Abstract] [Full Text] [Related]

  • 4. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
    Zidek W.
    MMW Fortschr Med; 2004 Oct 14; 146(42):51-2. PubMed ID: 15536706
    [No Abstract] [Full Text] [Related]

  • 5. [Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy].
    Nitschmann S, Girndt M, Köhler H.
    Internist (Berl); 2005 Aug 14; 46(8):923-4, 926. PubMed ID: 15990988
    [No Abstract] [Full Text] [Related]

  • 6. Telmisartan vs. enalapril in type 2 diabetes.
    Parving HH, Hovind P, Rossing P.
    N Engl J Med; 2005 Feb 24; 352(8):835-6; author reply 835-6. PubMed ID: 15736292
    [No Abstract] [Full Text] [Related]

  • 7. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH.
    Acta Diabetol; 2005 Apr 24; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduction of proteinuria with angiotensin receptor blockers.
    Galle J.
    Nat Clin Pract Cardiovasc Med; 2008 Jul 24; 5 Suppl 1():S36-43. PubMed ID: 18580865
    [Abstract] [Full Text] [Related]

  • 12. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A.
    Am J Med; 2006 May 24; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A hypertensive snow bird.
    Marlow B.
    CMAJ; 2005 Nov 22; 173(11):1357-8; discussion 1358. PubMed ID: 16301705
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure.
    Nakamura T, Sugaya T, Koide H.
    Diabetologia; 2007 Feb 22; 50(2):490-2. PubMed ID: 17171364
    [No Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM, Smith DH, Reilly PA.
    Int J Clin Pract; 1999 Feb 22; 53(3):175-8. PubMed ID: 10665127
    [Abstract] [Full Text] [Related]

  • 17. Impact of telmisartan on coronary stenting in patients with acute myocardial infarction compared with enalapril.
    Yokoyama J, Higuma T, Tomita H, Abe N, Oikawa K, Fujiwara T, Yokota T, Yokoyama H, Kimura M, Sasaki S, Hanada H, Osanai T, Okumura K.
    Int J Cardiol; 2009 Feb 06; 132(1):114-20. PubMed ID: 18190989
    [Abstract] [Full Text] [Related]

  • 18. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
    Barnett A.
    J Am Soc Nephrol; 2006 Apr 06; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
    [Abstract] [Full Text] [Related]

  • 19. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M, Tabuchi T, Minami Y, Takahashi Y, Itoh T, Nakamura M.
    Clin Ther; 2009 Oct 06; 31(10):2113-25. PubMed ID: 19922882
    [Abstract] [Full Text] [Related]

  • 20. eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.
    Kosugi T, Heinig M, Nakayama T, Matsuo S, Nakagawa T.
    Am J Pathol; 2010 Feb 06; 176(2):619-29. PubMed ID: 20042665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.